How to fine-tune molecular structures within vaccines to improve immune responses
A vaccine's molecular structure plays a key role in determining how the immune system responds and prepares to protect the body from future exposure to a specific pathogen. To develop a vaccine that offers long-term protection from HIV, it's essential to promote a long-lasting immune response in which immune cells and antibodies prepared to combat the virus persist within the body. This has…
Fine-tuning molecular structures within vaccines could significantly enhance immune responses, particularly in combating HIV. Scientists at Scripps Research, the University of Texas Medical Branch, and IAVI conducted preclinical studies to explore how increasing the avidity or overall binding strength of vaccine nanoparticles to specific white blood cells could improve immune responses.
By demonstrating that higher overall binding strength leads to stronger immune responses across various stages, these findings may guide the development of next-generation HIV vaccines. The researchers engineered vaccine nanoparticles with varying levels of repetitiveness and attachment-point binding strength to deconstruct their individual contributions to overall binding strength.
Their results indicate that repetitiveness plays a more dominant role in driving immune responses compared to attachment-point binding strength. This discovery could potentially lead to the design of more effective vaccines for HIV and other infectious diseases by optimizing the molecular structure of vaccine nanoparticles.
Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
